A 13-country survey finds menopause symptom burden varies enormously by country
The UK and Rwanda reported the highest anxiety, depression, and vasomotor symptom scores; Nepal, Sri Lanka, Malaysia, and Singapore reported the lowest. Burnout emerged as the symptom most connected to everything else.
Most menopause research has been conducted in high-income, Western populations, leaving evidence from low- and middle-income countries comparatively thin despite menopause affecting an expanding share of the global population as life expectancy rises. The MARIE Project's Global Chapter, published this month in EClinicalMedicine, is a deliberate attempt to close that gap, surveying women across 13 countries spanning multiple continents and income levels [s1].
The design
This cross-sectional quantitative analysis is part of a broader mixed-methods study conducted from January 2024 to September 2025 [s1]. Cisgender and transgender women experiencing perimenopause, menopause, or post-menopause were recruited digitally from clinical and community settings across the UK, Rwanda, Nigeria, Ghana, Tanzania, Sri Lanka, India, Pakistan, Nepal, Malaysia, Singapore, Oman, and Brazil [s1]. Symptom burden was assessed using validated scales covering psychological, somatic, pain, sleep, disability, and quality-of-life domains [s1]. Analyses included multivariable linear models, country-grouped heterogeneity models, and Gaussian Graphical Modelling — a statistical technique used to map how different symptoms interconnect with each other, rather than treating each symptom in isolation [s1].
What it found
A total of 5,228 participants across the 13 countries were included, with a median age of 55 (interquartile range 50–61) [s1]. Of these, 18.6% were in perimenopause, 32.2% in menopause, and 49.2% post-menopause [s1]. Symptom burden varied substantially both by country and by menopausal stage [s1]. The UK and Rwanda showed the highest levels of anxiety, depression, somatic symptom burden, vasomotor symptoms (hot flashes and related symptoms), and overall menopause rating scale scores, while Nepal, Sri Lanka, Malaysia, and Singapore consistently reported lower symptom burden across these same measures [s1]. Clinical complexity — including endometriosis, disability, other long-term health conditions, premature ovarian insufficiency, and use of GnRH analogue medications — was strongly associated with worse outcomes across the board [s1]. In the symptom-network modeling, burnout emerged as the most central symptom, meaning it was the symptom most closely connected to and predictive of other psychological and somatic symptoms within the network [s1].
Why the UK-and-Rwanda pairing is the study's most counterintuitive finding
A high-income country (UK) and a lower-income East African country (Rwanda) showing the highest combined symptom burden — while middle-income Asian countries (Sri Lanka, Malaysia) and a lower-income South Asian country (Nepal) showed the lowest — cuts directly against a simple assumption that symptom burden tracks straightforwardly with national income or healthcare access. That pattern suggests something other than resource availability alone is driving the country-level differences — potentially cultural or reporting differences in how women describe or are willing to disclose menopause symptoms, differences in stigma or social support structures, differences in underlying health-system stressors specific to each context, or genuine variation in symptom experience shaped by factors this cross-sectional survey design can't fully untangle.
Why the burnout-as-central-symptom finding matters
The Gaussian Graphical Modelling approach, treating symptoms as an interconnected network rather than a checklist, identifying burnout specifically as the most central node is a methodologically distinct contribution — it suggests that among the many psychological and somatic symptoms measured, burnout may function as something closer to a hub that connects to and potentially drives other symptom clusters, rather than being just one symptom among many with equal standing. That has a practical implication worth noting cautiously: if burnout is genuinely central to the broader symptom network, addressing it specifically — rather than only treating vasomotor or mood symptoms individually — might have outsized effects on overall symptom burden, though this cross-sectional network analysis can identify structural centrality without proving that intervening on burnout would causally improve other symptoms.
What this doesn't establish
This is cross-sectional survey data recruited digitally, which likely skews toward women with internet access and digital literacy — a real limitation for a study explicitly aiming to represent diverse global populations, since digital recruitment may systematically underrepresent the most resource-limited women within each country studied. The study cannot establish causation for any of the country-level or symptom-network associations described; it maps patterns rather than testing interventions. Sample sizes per individual country aren't detailed in the available summary, and with 13 countries sharing a total sample of 5,228, some individual country estimates likely rest on relatively modest numbers, which the paper's own reporting doesn't fully clarify.
What the researchers frame as the contribution
The study's authors position this as addressing "under-recognised" menopause health in global and policy discourse, particularly in low- and middle-income countries where evidence has been especially limited [s1] — framing the value of this data as foundational and descriptive, establishing where symptom burden concentrates globally, rather than as a study that identifies specific interventions or explains the mechanisms behind the patterns found.
What to watch
Whether the qualitative component of the broader MARIE Project mixed-methods study, not detailed in this quantitative paper, sheds light on why symptom burden diverges so sharply between the UK/Rwanda and Nepal/Sri Lanka/Malaysia clusters. This article is not medical advice.
Sources
Sources
More on
One in five midlife women said self-pleasure eased their menopause symptoms
Rated against other symptom-management strategies women already use, masturbation scored among the highest for relieving mood changes and sleep disturbance. Nearly half said they'd try it if a doctor suggested it.
Endometriosis does not always stop at menopause. A European guide says so
An EMAS clinical guide sets out how to manage endometriosis after menopause, advising against oestrogen-only hormone therapy even in women who have had a hysterectomy.
Social support and memory in postmenopausal women: a careful null
A secondary analysis of the ELITE hormone-therapy trial found hints that social ties tracked with cognition, but none survived correction for multiple testing.
Vaginal oestrogen around prolapse surgery: better symptoms, same anatomy
A 293-woman Dutch trial found more women reported improvement at 12 months with perioperative oestriol cream than placebo. Anatomical success, surgical success and reintervention were unchanged.